Patent · US Active

Mutant IDH1 inhibitors

US10696665B2 · kind B2 · utility

0Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 30, 2017
Grant dateJun 30, 2020
Priority date—
Expiry dateMay 30, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application provides compounds of Formula I: Formula (I) that are useful as inhibitors of mutant IDH1, pharmaceutical compositions, and uses for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.